Is Theranos Discontinued? What Happened? Scandal
Fate: Dissolved following regulatory actions and fraud charges; executives later convicted in U.S. federal court
Theranos was a U.S. blood-testing startup that claimed it could run hundreds of lab tests from a finger-prick of blood. Founded in 2003 by Elizabeth Holmes, the company pitched a compact analyzer for decentralized diagnostics and pursued retail pilots to place collection sites inside pharmacies. By the mid-2010s, Theranos had become a high-profile Silicon Valley brand with prominent investors, luminaries on its board, and extensive media coverage.
Behind the scenes, Theranos relied largely on modified third-party analyzers while its proprietary devices struggled with accuracy and reliability. In October 2015, a series of investigative reports questioned the company’s technology and quality controls. U.S. regulators subsequently inspected Theranos’s labs, citing serious deficiencies, and retail partnerships paused or wound down as scrutiny intensified.
In 2016, federal regulators banned Holmes from operating a clinical lab and moved to revoke the company’s CLIA certificate. The SEC charged Theranos and its executives in March 2018 with raising money through exaggerated and false statements. By September 2018, Theranos ceased operations and was dissolved. Later criminal proceedings resulted in convictions of the CEO and the former president. The collapse became a landmark case in medical-device governance, underscoring the need for rigorous validation, transparent performance data, and strong clinical oversight.
Timeline
-
2003
- April — Company founded by Elizabeth Holmes
-
2013
- September — Announces retail pharmacy pilot for blood testing
-
2015
- October 15 — Investigative reports question accuracy and lab practices
-
2016
- July 8 — Regulators ban Holmes from operating a lab; CLIA action
-
2018
- September 5 — Company dissolves after SEC charges and regulatory actions
Frequently Asked Questions
What was Theranos?
Theranos was a blood‑testing startup founded in 2003 by Elizabeth Holmes. It claimed it could run hundreds of lab tests using just a finger‑prick of blood.
Why did Theranos get so much attention?
The company promised fast, cheap, decentralized testing. It pitched a small analyzer that could sit in pharmacies and doctor's offices. Big investors, famous board members, and glowing media coverage helped build its reputation.
How was the technology supposed to work?
Theranos said its device could perform many tests from a tiny blood sample. If true, it would have changed how medical labs worked.
What was happening behind the scenes?
The proprietary devices didn't work reliably. Theranos often used modified third‑party lab machines instead of its own technology. Accuracy and quality‑control problems were widespread.
When did things start to unravel?
In October 2015, investigative reports questioned the company's technology and lab practices. Regulators inspected Theranos's labs and found serious issues. Retail partners paused or ended their pilot programs.
What did regulators do?
In 2016, federal regulators banned Holmes from running a clinical lab and moved to revoke Theranos's CLIA certificate. The company's testing operations could no longer continue.
What happened with investors and the SEC?
In March 2018, the SEC charged Theranos and its executives with raising money through exaggerated and false statements. The company settled without admitting wrongdoing, but the damage was done.
When did Theranos shut down?
Theranos dissolved in September 2018 after failing to recover from the investigations and regulatory actions.
Were there criminal charges?
Yes. Later criminal cases led to convictions of the CEO and the former president for fraud related to misleading investors and patients.
Why is the Theranos collapse so important?
It became a landmark case in medical‑device oversight. It showed why new health technologies need rigorous testing, transparent data, and strong regulatory checks before reaching patients.
Explore More
Learn more
Continue on Vanished Brands
Spotted an error or have additional sources? Get in touch and I'll review it.